QA: Navidea Biopharmaceuticals Inc. in us_medicinal_products/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000810509_2023_Navidea_Biopharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0000810509, Navidea Biopharmaceuticals Inc.

  xvar xval
0 LiabilitiesNoncurrent 1,312
1 LiabilitiesCurrent 9,941,889
2 remainder_Liabilities 2,571,715
3 AssetsCurrent 3,203,944
4 AssetsNoncurrent 32,074
5 PropertyPlantAndEquipmentNet 135,347
6 Goodwill 1,000,241
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 7,963,767
9 ResearchAndDevelopmentExpense 5,969,774
10 remainder_Expenses 183,006
11 remainder_Revenues 65,652
12 remainder_NetIncome -1,126,261
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Liabilities 12,514,916
1 Assets 4,371,606
2 Expenses 14,116,547
3 Revenues 65,652
4 StockholdersEquity -8,143,310
5 NetIncome -15,177,156
6 ComprehensiveNetIncome -15,177,156
7 BaseVar 16,097,491
8 EconomicCapitalRatio -2.62

Edgar->Model Mapping

Feature Distribution

Change over Time